To facilitate biomedical research of illness mechanisms, a high-quality interactome that connects functionally associated genes is required to assist investigators formulate pathway hypotheses and to interpret the organic logic of a phenotype on the organic course of stage. Interactions within the up to date model of the human interactome useful resource (HIR V2) had been inferred from 36 mathematical characterizations of six sorts of knowledge that recommend purposeful associations between genes. This replace of the HIR consists of 88 069 pairs of genes (23.2% purposeful interactions of HIR V2 are in widespread with the earlier model of HIR), representing purposeful associations which might be of strengths just like these between well-studied protein interactions.
Amongst these purposeful interactions, 57% could symbolize protein interactions, that are anticipated to cowl 32% of the true human protein interactome. The gene set linkage evaluation (GSLA) device is developed primarily based on the high-quality HIR V2 to determine the potential purposeful impacts of the noticed transcriptomic modifications, serving to to elucidate their organic significance and complementing the at present extensively used enrichment-based gene set interpretation instruments. A case examine exhibits that the annotations reported by the HIR V2/GSLA system are extra complete and concise in comparison with these obtained by the extensively used gene set annotation instruments akin to PANTHER and DAVID.
Relationships Between Cardio Efficiency, Hemoglobin Ranges, and Coaching Load Throughout Small-Sided Video games: A Research in Skilled Soccer Gamers
The needs of this examine had been (1) to investigate between-session variations of exterior and inside load measures throughout small-sided video games (SSGs) and (2) to check the relationships between the utmost pace reached (VIFT) over the last stage of the 30-15 Intermittent Health Check, hemoglobin ranges, and coaching load measures throughout SSG intervals amongst skilled soccer gamers.
Sixteen skilled soccer gamers (imply ± SD; age 27.2 ± 3.Four years, peak 174.2 ± 3.6 cm, physique mass 69.1 ± 6.Four kg, and physique fats 10.4 ± 4.1%) participated on this examine. Hemoglobin and cardio efficiency had been first examined, after which a 3-week SSG program was utilized utilizing a Three vs. Three format. Throughout these Three weeks, inside and exterior load of complete classes had been additionally monitored for all coaching classes.
Trivial-to-small, standardized variations had been noticed between classes for exterior and inside measures throughout SSGs. Whole distance (TD) and mechanical work (MW) had been the one variables that indicated small modifications. Massive-to-very-large relationships had been discovered between VIFT and exterior masses: TD (r vary: 0.69; 0.87), high-intensity working (HIR; r vary: 0.66; 0.75), and MW (r vary: 0.56; 0.68).
Average-to-large adverse relationships had been discovered between hemoglobin ranges and inside masses: Edwards’ TRIMP (r vary: -0.36; -0.63), %HRmax (r vary: -0.50; -0.61), and purple zone (r vary: -0.50; -0.61). VIFT had unclear relationships with total inside masses, whereas hemoglobin ranges offered unclear relationships with total exterior masses.
In conclusion, no significant modifications had been discovered between classes contemplating the format of play used. Moreover, the detected relationships point out that VIFT and hemoglobin ranges are good indicators of the efficiency capability and physiological profile of gamers throughout SSGs. Additionally, the usage of SSGs protocols as a monitoring complement of the 30-15IFT is recommended.
A benzene-bridged divanadium complex-early transition metallic catalyst for alkene alkylarylation with PhI(O 2 CR) 2by way of decarboxylation
The synthesis, construction and catalytic exercise of a benzene-bridged divanadium advanced had been comprehensively studied. The discount of (Nacnac)VCl2 (1) (Nacnac = (2,6-iPr2C6H3NCMe)2HC) supported by β-diketiminate with potassium graphite (KC8) by using benzene because the solvent permits entry to the benzene-bridged inverted-sandwich divanadium advanced (μ-η6:η6-C6H6)[V(Nacnac)]2 (2a), which might catalyze alkene alkylarylation with hypervalent iodine(iii) reagents (HIRs) by way of decarboxylation to generate regioselectively various indolinones. Moreover, the gentle nature of this response was amenable to a variety of functionalities on alkenes and HIRs. Mechanistic research revealed a relay sequence of decarboxylative radical alkylation/radical arylation/oxidative re-aromatization.
Focusing on autophagy to modulate hepatic ischemia/reperfusion damage: A comparative examine between octreotide and melatonin as autophagy modulators by way of AMPK/PI3K/AKT/mTOR/ULK1 and Keap1/Nrf2 signaling pathways in rats
Hepatic ischemia-reperfusion (HIR) damage is a typical pathophysiological course of in lots of scientific settings. This examine was designed to check the protecting position of octreotide (somatostatin analogue, OCT) and melatonin (N-acetyl-5-methoxytryptamine, MLT) by way of the modulation of autophagy towards HIR damage in rats. Male albino rats had been divided into sham, HIR, OCT at three doses (50, 75, and 100 μg/kg), MLT, MLT+OCT75, compound C (AMPK inhibitor, CC), and CC+OCT75 teams. Ischemia was induced for 30 min adopted by 24 h reperfusion. Biochemical, histopathological, immunohistochemical, lipid peroxidation, ELISA, qPCR, and western blot methods had been carried out in our examine.
Liver autophagy was restored by OCT at doses (50 or 75 μg/kg) as indicated by elevating the expressions of Beclin-1, ATG7, and LC3 accompanied by the discount of p62 expression by way of induction of AMPK/S317-ULK1 and inhibition of PI3K/AKT/mTOR/S757-ULK1 signaling pathways. As nicely, OCT maintained the integrity of the Keap1-Nrf2 system for the traditional hepatic capabilities by way of controlling the Keap1 turnover by way of autophagy in a p62-dependent method, leading to upholding a sequence of anti-oxidant and anti inflammatory cascades.
Rat Anti-Mouse TIM-1 (CD365) Monoclonal antibody, clone 3B3 |
|||
| CABT-L4302-1mg | Creative Diagnostics | 1 mg | EUR 1076.4 |
Rat Anti-Mouse TIM-1 (CD365) Monoclonal antibody, clone 3B3 |
|||
| CABT-L4302-5mg | Creative Diagnostics | 5 mg | EUR 2886 |
HIRIP3 Antibody |
|||
| 1-CSB-PA010372GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against HIRIP3. Recognizes HIRIP3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
|||
HIRIP3 antibody |
|||
| 70R-2185 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal HIRIP3 antibody raised against the middle region of HIRIP3 |
|||
HIRIP3 antibody |
|||
| 70R-17741 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal HIRIP3 antibody |
|||
HIRIP3 Antibody |
|||
| 39461-100ul | SAB | 100ul | EUR 468 |
HIRIP3 antibody |
|||
| 31854-100ul | SAB | 100ul | EUR 302.4 |
HIRIP3 antibody |
|||
| 31854-50ul | SAB | 50ul | EUR 224.4 |
HIRIP3 antibody |
|||
| 10R-1507 | Fitzgerald | 100 ug | EUR 614.4 |
|
Description: Mouse monoclonal HIRIP3 antibody |
|||
anti- HIRIP3 antibody |
|||
| FNab03871 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against HIRIP3 |
|||
HIRIP3 Polyclonal Antibody |
|||
| 30792-100ul | SAB | 100ul | EUR 302.4 |
HIRIP3 Polyclonal Antibody |
|||
| 30792-50ul | SAB | 50ul | EUR 224.4 |
Polyclonal HIRIP3 Antibody |
|||
| APR02968G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HIRIP3 . This antibody is tested and proven to work in the following applications: |
|||
Anti-HIRIP3 antibody |
|||
| PAab03871 | Lifescience Market | 100 ug | EUR 494.4 |
Anti-HIRIP3 antibody |
|||
| STJ29094 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: The HIRA protein shares sequence similarity with Hir1p and Hir2p, the two corepressors of histone gene transcription characterized in the yeast, Saccharomyces cerevisiae. The structural features of the HIRA protein suggest that it may function as part of a multiprotein complex. Several cDNAs encoding HIRA-interacting proteins, or HIRIPs, have been identified. In vitro, the protein encoded by this gene binds HIRA, as well as H2B and H3 core histones, indicating that a complex containing HIRA-HIRIP3 could function in some aspects of chromatin and histone metabolism. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. |
|||
Mouse HIRIP3 shRNA Plasmid |
|||
| 20-abx982088 | Abbexa |
|
|
HIRIP3 Recombinant Protein (Mouse) |
|||
| RP141530 | ABM | 100 ug | Ask for price |
HIRIP3 siRNA |
|||
| 20-abx919397 | Abbexa |
|
|
HIRIP3 siRNA |
|||
| 20-abx919398 | Abbexa |
|
|
pOTB7-HIRIP3 |
|||
| PVT18716 | Lifescience Market | 2 ug | EUR 277.2 |
anti-HIRIP3 |
|||
| YF-PA15655 | Abfrontier | 50 ul | EUR 435.6 |
|
Description: Mouse polyclonal to HIRIP3 |
|||
anti-HIRIP3 |
|||
| YF-PA15656 | Abfrontier | 50 ug | EUR 435.6 |
|
Description: Mouse polyclonal to HIRIP3 |
|||
Anti-ASFV P72 Antibody | MASF-5A-Clone #10E11 |
|||
| MASF-5A-Clone-10E11 | Immunology Consultants Laboratory | 1 mg | EUR 667 |
|
Description: Anti-ASFV P72 Antibody | MASF-5A-Clone #10E11 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Anti-ASFV P72 Antibody | MASF-5A-Clone #10G5 |
|||
| MASF-5A-Clone-10G5 | Immunology Consultants Laboratory | 1 mg | EUR 667 |
|
Description: Anti-ASFV P72 Antibody | MASF-5A-Clone #10G5 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Monoclonal Ku (p70/p80)Mouse Monoclonal Antibody [Clone KU729], Clone: KU729 |
|||
| AMM00210G | Leading Biology | 0.5ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human Ku (p70/p80)Mouse Monoclonal [Clone KU729]. The antibodies are raised in Mouse and are from clone KU729. This antibody is applicable in IF, FC |
|||
HIRIP3 Polyclonal Conjugated Antibody |
|||
| C30792 | SAB | 100ul | EUR 476.4 |
HIRIP3 Polyclonal Conjugated Antibody |
|||
| C31854 | SAB | 100ul | EUR 476.4 |
Polyclonal HIRIP3 Antibody (Center) |
|||
| APR16639G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HIRIP3 (Center). This antibody is tested and proven to work in the following applications: |
|||
Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#3B11 |
|||
| MALV-30A-Clone-3B11 | Immunology Consultants Laboratory | 1.0 mg | EUR 448 |
|
Description: Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#3B11 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#5A4 |
|||
| MALV-30A-Clone-5A4 | Immunology Consultants Laboratory | 1.0 mg | EUR 448 |
|
Description: Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#5A4 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#6C2 |
|||
| MALV-30A-Clone-6C2 | Immunology Consultants Laboratory | 1.0 mg | EUR 448 |
|
Description: Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#6C2 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#6D7 |
|||
| MALV-30A-Clone-6D7 | Immunology Consultants Laboratory | 1.0 mg | EUR 448 |
|
Description: Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#6D7 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Hirip3 ORF Vector (Mouse) (pORF) |
|||
| ORF047178 | ABM | 1.0 ug DNA | EUR 607.2 |
Monoclonal mouse Splunc2 Antibody, Clone: 1F12 |
|||
| APR07136G | Leading Biology | 0.1ml | EUR 633.6 |
|
Description: A Monoclonal antibody against Human mouse Splunc2. The antibodies are raised in Mouse and are from clone 1F12. This antibody is applicable in WB and IHC, FC, ICC, E |
|||
Monoclonal mouse Lplunc1 Antibody, Clone: 4H2 |
|||
| APR08492G | Leading Biology | 0.1ml | EUR 633.6 |
|
Description: A Monoclonal antibody against Human mouse Lplunc1. The antibodies are raised in Mouse and are from clone 4H2. This antibody is applicable in WB and IHC, FC, ICC, E |
|||
Monoclonal mouse Lplunc1 Antibody, Clone: 1F11E3 |
|||
| APR08493G | Leading Biology | 0.1ml | EUR 633.6 |
|
Description: A Monoclonal antibody against Human mouse Lplunc1. The antibodies are raised in Mouse and are from clone 1F11E3. This antibody is applicable in WB, E |
|||
Monoclonal Mouse Bmi1 Antibody, Clone: 353CT22.4.4 |
|||
| AMM02383G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human Mouse Bmi1. The antibodies are raised in Mouse and are from clone 353CT22.4.4. This antibody is applicable in WB, E |
|||
anti-RAB7B (3B3) |
|||
| LF-MA10271 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to RAB7B |
|||
Anti-RAX (3B3) |
|||
| YF-MA18303 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to RAX |
|||
Anti-HES2 (3B3) |
|||
| YF-MA18677 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to HES2 |
|||
Anti-CTNNBIP1 (3B3) |
|||
| YF-MA19005 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to CTNNBIP1 |
|||
Anti-CABP4 (3B3) |
|||
| YF-MA19007 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to CABP4 |
|||
Anti-MTA3 (3B3) |
|||
| YF-MA19060 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to MTA3 |
|||
Anti-BPOZ (3B3) |
|||
| YF-MA19413 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to BPOZ |
|||
Anti-Olig1 (3B3) |
|||
| YF-MA19770 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to Olig1 |
|||
Anti-SERPINA12 (3B3) |
|||
| YF-MA19907 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to SERPINA12 |
|||
Anti-STK32A (3B3) |
|||
| YF-MA20023 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to STK32A |
|||
Anti-JNK1 (3B3) |
|||
| YF-MA14907 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to JNK1 |
|||
Anti-Peripherin (3B3) |
|||
| YF-MA14965 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to Peripherin |
|||
Anti-synaptophysin (3B3) |
|||
| YF-MA15691 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to synaptophysin |
|||
Anti-LIPF (3B3) |
|||
| YF-MA16392 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to LIPF |
|||
Anti-Glyt2 (3B3) |
|||
| YF-MA16694 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to Glyt2 |
|||
Anti-HEY1 (3B3) |
|||
| YF-MA11407 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to HEY1 |
|||
Anti-ALDOB (3B3) |
|||
| YF-MA11897 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to ALDOB |
|||
Monoclonal S100A8 Antibody (Clone IMG48M7C7), Clone: Clone IMG48M7C7 |
|||
| AMM00015G | Leading Biology | 0.1mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human S100A8 (Clone IMG48M7C7). The antibodies are raised in Mouse and are from clone Clone IMG48M7C7. This antibody is applicable in WB and IHC |
|||
Monoclonal PDGFR Antibody (Clone # 275CT1), Clone: Clone # 275CT1 |
|||
| AMM00020G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human PDGFR (Clone # 275CT1). The antibodies are raised in Mouse and are from clone Clone # 275CT1. This antibody is applicable in WB |
|||
Monoclonal NGFR Antibody (Clone # 8G3G10), Clone: Clone # 8G3G10 |
|||
| AMM06686G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human NGFR (Clone # 8G3G10). The antibodies are raised in Mouse and are from clone Clone # 8G3G10. This antibody is applicable in WB and IF, FC |
|||
Monoclonal CD28 FITC Monoclonal Antibody (Clone CD28.2), Clone: CD28.2 |
|||
| AMM00025G | Leading Biology | 0.05mg | EUR 475.2 |
|
Description: A Monoclonal antibody against Human CD28 FITC Monoclonal (Clone CD28.2). The antibodies are raised in Mouse and are from clone CD28.2. This antibody is applicable in FC |
|||
Monoclonal CD11c FITC Monoclonal Antibody (Clone 3.9), Clone: 3.9 |
|||
| APR15331G | Leading Biology | 50 tests | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD11c FITC Monoclonal (Clone 3.9). The antibodies are raised in Mouse and are from clone 3.9. This antibody is applicable in FC |
|||
HIRIP3 cloning plasmid |
|||
| CSB-CL883612HU-10ug | Cusabio | 10ug | EUR 451.2 |
|
Description: A cloning plasmid for the HIRIP3 gene. |
|||
HIRIP3 Blocking Peptide |
|||
| 33R-8235 | Fitzgerald | 100 ug | EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of HIRIP3 antibody, catalog no. 70R-2185 |
|||
HIRIP3 Rabbit pAb |
|||
| A7014-100ul | Abclonal | 100 ul | EUR 369.6 |
HIRIP3 Rabbit pAb |
|||
| A7014-200ul | Abclonal | 200 ul | EUR 550.8 |
HIRIP3 Rabbit pAb |
|||
| A7014-20ul | Abclonal | 20 ul | EUR 219.6 |
HIRIP3 Rabbit pAb |
|||
| A7014-50ul | Abclonal | 50 ul | EUR 267.6 |
Monoclonal CST3 Antibody (monoclonal), Clone: 1H4 |
|||
| AMM03425G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CST3 (monoclonal). The antibodies are raised in Mouse and are from clone 1H4. This antibody is applicable in WB |
|||
Monoclonal TNFSF18 Antibody (monoclonal), Clone: 2E11 |
|||
| AMM04221G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human TNFSF18 (monoclonal). The antibodies are raised in mouse and are from clone 2E11. This antibody is applicable in WB, E |
|||
Monoclonal FTL Antibody (monoclonal), Clone: 4G7 |
|||
| AMM04622G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human FTL (monoclonal). The antibodies are raised in Mouse and are from clone 4G7. This antibody is applicable in WB, E |
|||
Monoclonal FADD Antibody (Clone T1B), Clone: T1B |
|||
| AMM00001G | Leading Biology | 0.1mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human FADD (Clone T1B). The antibodies are raised in Mouse and are from clone T1B. This antibody is applicable in WB and IF |
|||
Monoclonal p53 Antibody (Clone C6A5), Clone: C6A5 |
|||
| AMM00003G | Leading Biology | 0.1mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human p53 (Clone C6A5). The antibodies are raised in Mouse and are from clone C6A5. This antibody is applicable in WB and IHC, ICC, IP |
|||
Monoclonal IkBalpha Antibody (Clone 6A055), Clone: 6A055 |
|||
| AMM00004G | Leading Biology | 0.1mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human IkBalpha (Clone 6A055). The antibodies are raised in Mouse and are from clone 6A055. This antibody is applicable in WB and IHC, IP |
|||
Monoclonal ROCK1 Antibody (Clone 12M03), Clone: 12M03 |
|||
| AMM00007G | Leading Biology | 0.1mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human ROCK1 (Clone 12M03). The antibodies are raised in Mouse and are from clone 12M03. This antibody is applicable in WB |
|||
Monoclonal CD3 Antibody (Clone OKT3), Clone: OKT3 |
|||
| AMM00016G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD3 (Clone OKT3). The antibodies are raised in Mouse and are from clone OKT3. This antibody is applicable in FC |
|||
Monoclonal PODXL Antibody [Clone 2A4], Clone: 2A4 |
|||
| AMM00040G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human PODXL [Clone 2A4]. The antibodies are raised in Mouse and are from clone 2A4. This antibody is applicable in WB, IHC and IF, FC, IP |
|||
Monoclonal PODXL Antibody [Clone 4F10], Clone: 4F10 |
|||
| AMM00051G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human PODXL [Clone 4F10]. The antibodies are raised in Mouse and are from clone 4F10. This antibody is applicable in WB, IHC and IF, FC, IP |
|||
Monoclonal CD20 Antibody [Clone B9E9], Clone: B9E9 |
|||
| AMM00065G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD20 [Clone B9E9]. The antibodies are raised in Mouse and are from clone B9E9. This antibody is applicable in FC |
|||
Monoclonal CD20 Antibody [Clone B9E9], Clone: B9E9 |
|||
| AMM00066G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD20 [Clone B9E9]. The antibodies are raised in Mouse and are from clone B9E9. This antibody is applicable in FC |
|||
Monoclonal C4d Antibody [Clone C4D203], Clone: C4D203 |
|||
| AMM00080G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human C4d [Clone C4D203]. The antibodies are raised in Mouse and are from clone C4D203. This antibody is applicable in IF |
|||
Monoclonal C4d Antibody [Clone C4D205], Clone: C4D205 |
|||
| AMM00082G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human C4d [Clone C4D205]. The antibodies are raised in Mouse and are from clone C4D205. This antibody is applicable in IF |
|||
Monoclonal Vimentin Antibody [Clone LN6], Clone: LN6 |
|||
| AMM00156G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human Vimentin [Clone LN6]. The antibodies are raised in Mouse and are from clone LN6. This antibody is applicable in WB, IHC and IF |
|||
Monoclonal C4d Antibody [Clone TDM16], Clone: TDM16 |
|||
| AMM00188G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human C4d [Clone TDM16]. The antibodies are raised in Mouse and are from clone TDM16. This antibody is applicable in IF |
|||
Monoclonal RAPGEF6 Antibody (clone 2C5), Clone: 2C5 |
|||
| AMM07531G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human RAPGEF6 (clone 2C5). The antibodies are raised in Mouse and are from clone 2C5. This antibody is applicable in WB and IHC-P, IF, E |
|||
Monoclonal SOCS1 Antibody (clone 4H1), Clone: 4H1 |
|||
| AMM07943G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human SOCS1 (clone 4H1). The antibodies are raised in Mouse and are from clone 4H1. This antibody is applicable in WB and IHC-P |
|||
Monoclonal STK16 Antibody (clone M2), Clone: M2 |
|||
| AMM08020G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human STK16 (clone M2). The antibodies are raised in Mouse and are from clone M2. This antibody is applicable in WB and IHC-P, E, RNAi |
|||
Monoclonal STK33 Antibody (clone 3F10), Clone: 3F10 |
|||
| AMM08027G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human STK33 (clone 3F10). The antibodies are raised in Mouse and are from clone 3F10. This antibody is applicable in WB and IHC-P, IF, E |
|||
Monoclonal CD33 Antibody [Clone WM53], Clone: WM53 |
|||
| AMM00203G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD33 [Clone WM53]. The antibodies are raised in Mouse and are from clone WM53. This antibody is applicable in FC |
|||
Monoclonal CD33 Antibody [Clone WM53], Clone: WM53 |
|||
| AMM00204G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD33 [Clone WM53]. The antibodies are raised in Mouse and are from clone WM53. This antibody is applicable in FC |
|||
Monoclonal PARP Antibody (Clone 10H), Clone: 10H |
|||
| APR08930G | Leading Biology | 0.1mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human PARP (Clone 10H). The antibodies are raised in Mouse and are from clone 10H. This antibody is applicable in WB, ICC, E, IP |
|||
Monoclonal PARP Antibody (Clone 7A10), Clone: 7A10 |
|||
| APR08931G | Leading Biology | 0.1ml | EUR 633.6 |
|
Description: A Monoclonal antibody against Human PARP (Clone 7A10). The antibodies are raised in Mouse and are from clone 7A10. This antibody is applicable in WB, FC, ICC |
|||
Monoclonal PARP1 Antibody (clone A6.4.12), Clone: A6.4.12 |
|||
| APR08939G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human PARP1 (clone A6.4.12). The antibodies are raised in Mouse and are from clone A6.4.12. This antibody is applicable in WB and IHC-P, E, IP, IHC-Fr |
|||
Monoclonal PAWR Antibody (clone 3G9H7,4H12E9), Clone: 3G9H7,4H12E9 |
|||
| APR08945G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human PAWR (clone 3G9H7,4H12E9). The antibodies are raised in Mouse and are from clone 3G9H7,4H12E9. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal PCSK1 Antibody (clone 3D2), Clone: 3D2 |
|||
| APR08955G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human PCSK1 (clone 3D2). The antibodies are raised in Mouse and are from clone 3D2. This antibody is applicable in WB and IHC-P, IF, E |
|||
Monoclonal PDK2 Antibody (clone 2G1), Clone: 2G1 |
|||
| APR09004G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human PDK2 (clone 2G1). The antibodies are raised in Mouse and are from clone 2G1. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal PDK2 Antibody (clone 5F8), Clone: 5F8 |
|||
| APR09005G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human PDK2 (clone 5F8). The antibodies are raised in Mouse and are from clone 5F8. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal PDZK1 Antibody (clone AT1A2), Clone: AT1A2 |
|||
| APR09030G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human PDZK1 (clone AT1A2). The antibodies are raised in Mouse and are from clone AT1A2. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal PGD Antibody (clone 2A5), Clone: 2A5 |
|||
| APR09072G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human PGD (clone 2A5). The antibodies are raised in Mouse and are from clone 2A5. This antibody is applicable in WB and IHC-P, IF |
|||
Monoclonal SLC13A5 Antibody (clone 2G4), Clone: 2G4 |
|||
| APR09978G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human SLC13A5 (clone 2G4). The antibodies are raised in Mouse and are from clone 2G4. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal SLC22A1 Antibody (clone 2C5), Clone: 2C5 |
|||
| APR10013G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human SLC22A1 (clone 2C5). The antibodies are raised in Mouse and are from clone 2C5. This antibody is applicable in WB and IHC-P, E, Flo |
|||
Monoclonal SMAD3 Antibody (clone 2C12), Clone: 2C12 |
|||
| APR10161G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human SMAD3 (clone 2C12). The antibodies are raised in Mouse and are from clone 2C12. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal SMAD3 Antibody (clone AF9F7), Clone: AF9F7 |
|||
| APR10162G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human SMAD3 (clone AF9F7). The antibodies are raised in Mouse and are from clone AF9F7. This antibody is applicable in WB and IHC-P, E, IP |
|||
Monoclonal SOCS3 Antibody (clone SO1), Clone: SO1 |
|||
| APR10171G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human SOCS3 (clone SO1). The antibodies are raised in Mouse and are from clone SO1. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal SOD3 Antibody (clone 1H12), Clone: 1H12 |
|||
| APR10200G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human SOD3 (clone 1H12). The antibodies are raised in Mouse and are from clone 1H12. This antibody is applicable in WB and IHC-P, E, IP |
|||
Monoclonal STAT1 Antibody (clone AT1FA), Clone: AT1FA |
|||
| APR10265G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human STAT1 (clone AT1FA). The antibodies are raised in Mouse and are from clone AT1FA. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal STAT1 Antibody (clone SM1), Clone: SM1 |
|||
| APR10266G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human STAT1 (clone SM1). The antibodies are raised in Mouse and are from clone SM1. This antibody is applicable in WB and IHC-P, IP |
|||
Monoclonal STAT5A Antibody (clone 9F7), Clone: 9F7 |
|||
| APR10279G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human STAT5A (clone 9F7). The antibodies are raised in Mouse and are from clone 9F7. This antibody is applicable in WB and IHC-P, IF, Flo |
|||
Monoclonal STAT5B Antibody (clone 2D1), Clone: 2D1 |
|||
| APR10281G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human STAT5B (clone 2D1). The antibodies are raised in Mouse and are from clone 2D1. This antibody is applicable in WB and IHC-P, IF, E |
|||
Monoclonal STAT5B Antibody (clone 5D6), Clone: 5D6 |
|||
| APR10282G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human STAT5B (clone 5D6). The antibodies are raised in Mouse and are from clone 5D6. This antibody is applicable in WB and IHC-P, IF, E |
|||
Monoclonal TDO2 Antibody (clone 4G2), Clone: 4G2 |
|||
| APR10390G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human TDO2 (clone 4G2). The antibodies are raised in Mouse and are from clone 4G2. This antibody is applicable in WB and IHC-P |
|||
Monoclonal TOM20 Antibody (clone 4F3), Clone: 4F3 |
|||
| APR10504G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human TOM20 (clone 4F3). The antibodies are raised in Mouse and are from clone 4F3. This antibody is applicable in WB and IHC-P, IF, E |
|||
Monoclonal UQCRC1 Antibody (clone 1G6), Clone: 1G6 |
|||
| APR10666G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human UQCRC1 (clone 1G6). The antibodies are raised in Mouse and are from clone 1G6. This antibody is applicable in WB and IHC-P, Flo |
|||
Monoclonal VCP Antibody (clone 4A8), Clone: 4A8 |
|||
| APR10681G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human VCP (clone 4A8). The antibodies are raised in Mouse and are from clone 4A8. This antibody is applicable in WB and IHC-P, E |
|||
These results had been abolished by compound C. However, MLT confirmed a lower within the autophagy markers by way of inhibiting AMPK/pS317-ULK1 and activating PI3K/AKT/mTOR/pS757-ULK1 pathways. Autophagy inhibition with MLT markedly reversed the hepatoprotective results of OCT75 after HIR damage. Lastly, our outcomes proved for the primary time that OCT75 was more practical than MLT because it was ample to induce protecting autophagy in our HIR mannequin, which led to the induction of Nrf2-dependent AMPK/autophagy pathways.